Literature DB >> 1893812

Effects of verapamil and diltiazem on gastric emptying in normal subjects.

R T Yavorski1, S E Hallgren, P W Blue.   

Abstract

It has been suggested that calcium-channel blockers may delay gastric emptying by inhibiting gastric smooth muscle contraction. Most reports in man, however, reveal no significant delay in gastric emptying after using nifedipine; other calcium-channel blockers have not been studied in humans to date. We studied the effects of verapamil and diltiazem on solid-phase gastric emptying in 10 healthy volunteers. Each subject underwent a radionuclide gastric emptying determination (1) without preadministered medication, (2) after verapamil 80 mg orally every 6 hr for 10 doses, and (3) after diltiazem 60 mg by mouth given as one dose. Results revealed no significant difference in gastric emptying rates after pretreatment with verapamil or diltiazem when compared with no premedication (P greater than 0.37). We conclude that verapamil and diltiazem do not significantly delay gastric emptying in normal subjects. These data may be of clinical significance when prescribing calcium-channel blockers to patients with diseases associated with altered gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893812     DOI: 10.1007/bf01307521

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Effect of nifedipine on gastric emptying.

Authors:  R A Goetsch; S Fink; T K Chaudhuri
Journal:  Mil Med       Date:  1986-08       Impact factor: 1.437

Review 2.  Effects of calcium and calcium antagonists on the excitation-contraction coupling in striated and smooth muscle.

Authors:  K E Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978

3.  Control of the contractile mechanism of smooth and cardiac muscle.

Authors:  E Bozler
Journal:  Am J Physiol       Date:  1968-08

4.  Calcium channel blocking agents. Council on scientific affairs.

Authors: 
Journal:  JAMA       Date:  1983-11-11       Impact factor: 56.272

Review 5.  Calcium-channel blockers and the gastrointestinal tract. American College of Gastroenterology's Committee on FDA related matters.

Authors:  M Traube; R W McCallum
Journal:  Am J Gastroenterol       Date:  1984-11       Impact factor: 10.864

6.  Statistics and ethics in medical research: III How large a sample?

Authors:  D G Altman
Journal:  Br Med J       Date:  1980-11-15

7.  Differential effects of the calcium-antagonistic vasodilators, nifedipine and verapamil, on the tracheal musculature and vasculature of the dog.

Authors:  N Himori; N Taira
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

Review 8.  Pharmacokinetics of diltiazem and other calcium entry blockers.

Authors:  P Hermann; P L Morselli
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1985

9.  Effect of nifedipine on gastric emptying and gastrointestinal motility in man.

Authors:  R Santander; I Mena; M Gramisu; J E Valenzuela
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

10.  Pharmacokinetics and metabolism of diltiazem in man.

Authors:  V Rovei; R Gomeni; M Mitchard; J Larribaud; C Blatrix; J J Thebault; P L Morselli
Journal:  Acta Cardiol       Date:  1980       Impact factor: 1.718

View more
  6 in total

Review 1.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

2.  Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat.

Authors:  Sheila Annie Peters; Leif Hultin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-26       Impact factor: 2.745

3.  Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Aging and intestinal motility: a review of factors that affect intestinal motility in the aged.

Authors:  Denis O'Mahony; Paula O'Leary; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Intestinal Efflux Transporters P-gp and BCRP Are Not Clinically Relevant in Apixaban Disposition.

Authors:  Jasleen K Sodhi; Shuaibing Liu; Leslie Z Benet
Journal:  Pharm Res       Date:  2020-09-29       Impact factor: 4.200

Review 6.  Disorders of gastrointestinal hypomotility.

Authors:  Klaus Bielefeldt; Ashok Tuteja; Salman Nusrat
Journal:  F1000Res       Date:  2016-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.